<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">South Africa has remarkable successes in treatment of infectious diseases that include HIV and TB, malaria and others. This is evidenced by the increase in life expectancy over the years. The increase stems from the implementation of some health initiatives that include the use of antiretroviral agents for people living with HIV [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Although an outstanding progress has been made in reducing morbidity and mortality rates due to infectious diseases, new microbial resistance mechanisms threaten prevention and treatment procedures [
 <xref ref-type="bibr" rid="CR2">2</xref>]. This is due mainly to inadequate dosing, poor quality drugs, and genetic plasticity of the microorganisms [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Without effective antimicrobial agents, the success of even minor surgeries can be of a great challenge [
 <xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, joint efforts to discover and develop new drugs is imperial.
</p>
